In letter to the editor "Comment on: Statin use andrisk of diabetes mellitus" authors found the statement "pravastatin 40 mg/d reduced the risk of diabetes by 30% in West of Scotland Coronary Prevention study" erroneo...
In manuscript named "Statin use and risk of diabetes mellitus" by Chogtu et al, authors defined that pravastatin 40 mg/dL reduced the risk of diabetes by 30% in West of Scotland Coronary Prevention study. In fact, pra...
Supported by MBRS-RISE,No.R25-GM061838;and RCMI,No.G12-RR03051
AIM: To investigate if the effect of statins improving cardiovascular(CV) status of diabetics is drug-specific or class-dependent, and the underlying mechanisms involved.MET HOD S : We compared the results of daily ad...
supported by grants from the National Natural Science Foundation of China(81274109,30973238);Key Research Project of Beijing Natural Science Foundation(B)/Beijing Education Committee(KZ201010025024);Science and Technology Innovation Platform(PXM2011_014226_07_000085).
Background:Ongoing low-grade inflammation and endothelial dysfunction persist in children with coronary lesions diagnosed with Kawasaki disease(KD).Statins,frequently used in the management of high cholesterol,have al...
Recent data suggest that, in addition to improving dyslipidemia, statin may reduce the risk of infections and infection-related complications. The aim of this study is to make a review of the literature about the effe...
Objective:To investigate the impacts of Xuezhikang(血脂康,XZK)or pravastatin combined with antihypertensive drugs on circulating endothelial progenitor cells(CEPCs)in essential hypertensive (EH)patients.Methods:Eighty...